Related Experiment Video
Updated: Feb 21, 2026

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
Preventable complications in epilepsy admissions: The "July effect"
Natalie S Pierson1, Daniel R Kramer2, Timothy Wen1
1Keck School of Medicine at USC, Los Angeles, CA, United States.
Epilepsy patients admitted in July experienced slightly more hospital-acquired complications but had lower mortality, prolonged length of stay, and total charges. This suggests hospital supervision effectively manages potential July admission risks.
Area of Science:
- Neurology
- Healthcare Management
- Patient Safety
Background:
- Inpatient epilepsy care poses a significant burden on patients and healthcare systems.
- July admissions are anecdotally linked to increased complications due to new medical staff.
- Understanding factors influencing epilepsy admission outcomes is crucial for cost-effective strategies.
Purpose of the Study:
- To determine if epilepsy patients admitted in July face higher rates of preventable complications and mortality.
- To compare outcomes of July epilepsy admissions against non-July admissions.
Main Methods:
- Utilized data from the Nationwide Inpatient Sample (NIS) for epilepsy admissions from 2000-2010.
- Employed multivariable analyses to assess the impact of July admission on hospital-acquired complications (HAC) and mortality.
- Compared total adjusted charges and prolonged length of stay (pLOS) for July admissions against the 50th percentile.
Main Results:
- July admissions showed a slight increase in HAC events (RR=1.02) but a decrease in mortality (RR=0.96).
- No significant difference was found in total adjusted charges for July admissions (RR=1.00).
- Prolonged length of stay (pLOS) decreased for July admissions (RR=0.99).
Conclusions:
- July epilepsy admissions are associated with a minor increase in hospital-acquired complications.
- Despite increased complications, July admissions did not lead to worse outcomes in mortality, length of stay, or total charges.
- Existing hospital supervision appears adequate to mitigate risks associated with July admissions in epilepsy patients.
More Related Videos
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...